Sachan Anjali, Gupta Seema, Singh Navin
MD, Department of Radiotherapy, King George's Medical University, Lucknow, Uttar Pradesh, India.
PhD, Department of Radiotherapy, King George's Medical University, Lucknow, Uttar Pradesh, India.
J Biomed Phys Eng. 2022 Feb 1;12(1):83-90. doi: 10.31661/jbpe.v0i0.2007-1132. eCollection 2022 Feb.
Multimodality treatment is required for the management of head and neck cancer. Functional impairment and toxicities associated with surgery and radiation accentuate the need to develop innovative therapeutic strategies in the management of these patients to improve survival and reduce toxicity. In this study, we have compared treatment effects in patients of advanced head and neck squamous cell cancer treated by open field and 3DCRT treatment planning techniques.
This study aims to evaluate open field and 3DCRT treatment planning techniques in advanced head and neck squamous cell cancer patients managed by chemoradiation in the scenario of limited resources.
In this analytical study, 40 histologically proven unresectable advanced squamous cell carcinoma patients of oropharynx and larynx were allocated in two groups to receive 70 Gy in 35 fractions in 7 weeks with concurrent cisplatinum35 mg/m weekly either with open-field technique or three dimensional conformal radiotherapy (3DCRT) by ElektaSynergy linear accelerator. Target volume coverage and dose received by organ at risk (OARs) were compared. Clinical outcome in terms of response and toxicities is also evaluated in this study.
Plans with best possible coverage of the target volume were obtained. No significant difference was found in the dose received by the spinal cord; however, it was possible to prevent higher dose to brain stem with 3DCRTin node negative patients of oropharynx cancer and larynx cancer. Skin toxicities were significantly lower in 3DCRT arm.
In low resource settings with increased burden of locally advanced disease, both open-field and 3DCRT treatment techniques are comparable in terms of target coverage, OARs preservation, toxicity and treatment response.
头颈部癌的治疗需要多模式治疗。与手术和放疗相关的功能障碍和毒性凸显了在这些患者的治疗中开发创新治疗策略以提高生存率和降低毒性的必要性。在本研究中,我们比较了采用开放野和三维适形放疗(3DCRT)治疗计划技术治疗的晚期头颈部鳞状细胞癌患者的治疗效果。
本研究旨在评估在资源有限的情况下,采用放化疗治疗的晚期头颈部鳞状细胞癌患者中开放野和3DCRT治疗计划技术的效果。
在这项分析性研究中,40例经组织学证实为不可切除的口咽和喉鳞状细胞癌晚期患者被分为两组,采用开放野技术或Elekta Synergy直线加速器进行三维适形放疗(3DCRT),在7周内分35次给予70 Gy,同时每周给予顺铂35 mg/m²。比较靶区覆盖情况和危及器官(OARs)所接受的剂量。本研究还评估了反应和毒性方面的临床结果。
获得了靶区覆盖尽可能好的计划。脊髓所接受的剂量没有显著差异;然而,对于口咽癌和喉癌的淋巴结阴性患者,3DCRT可以避免脑干接受更高剂量。3DCRT组的皮肤毒性显著更低。
在局部晚期疾病负担增加的低资源环境中,开放野和3DCRT治疗技术在靶区覆盖、OARs保护、毒性和治疗反应方面具有可比性。